Healthcare Industry News: Fixation System
News Release - July 11, 2013
Medtronic Announces New Screw for Market-Leading CD HORIZON(R) SOLERA(R) Spinal System
MEMPHIS, Tenn. -- July 11, 2013 --(Healthcare Sales & Marketing Network)-- Medtronic, Inc. (NYSE:MDT) today announced the global market introduction of the CD HORIZON® SOLERA® Spinal System Sagittal Adjusting Screw (SAS) which may be used in the surgical correction of complex spinal pathologies. The SAS features a fixed head made of cobalt chrome that contains a sliding saddle. This engineering concept gives vertebral body control with accommodation of rod seating, allowing surgeons the ability to position the SAS in the natural kyphotic (outward) and lordotic (inward) curves of the spine.The worldwide launch of the Sagittal Adjusting Screw coincides with the International Meeting on Advanced Spine Techniques (IMAST) being held this week in Vancouver, Canada.
"The Sagittal Adjusting Screw is another key element in enhancing the capability of our CD HORIZON® SOLERA® pedicle Fixation System," said Doug King, Medtronic senior vice president and president of Medtronic Spinal. "It brings new innovation to the market and extends our industry-leading portfolio of spinal therapies."
About the CD HORIZON® SOLERA® Spinal System
The CD HORIZON® SOLERA® Spinal System is Medtronic's fifth-generation spinal fusion system and is cleared to treat patients with degenerative disc disease, spinal stenosis, fracture, dislocation, failed previous fusions, tumors and, adolescent idiopathic scoliosis. The system accommodates multiple rod material options and gives surgeons and hospitals an array of choices to treat a diverse set of spinal conditions.
Risks associated with such a system include loosening, disassembly, bending, and/or breakage of components, fracture, microfracture, resorption, damage, or penetration of any spinal bone. Selection of the proper size, shape, and design of the implant for each patient is crucial to its safe use. A successful result is not always achieved in every surgical case. The safety and effectiveness of this device has not been established for use as part of a growing rod construct when used in pediatric cases, and is only intended to be used when definitive fusion is being performed at all instrumented levels.
About the Spinal Business at Medtronic
Medtronic's Spinal business, based in Memphis, Tenn., is the global leader in today's spine market and is committed to advancing the treatment of spinal conditions. The Spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art products and technologies for orthopaedic and spinal conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies. More information about the company and its spinal treatments can be found at www.medtronic.com.
About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Source: Medtronic
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
